Assort Health ARR Hits $3 M

Assort Health, an AI startup focused on automating patient phone calls for specialty healthcare practices, has surpassed an annual recurring revenue (ARR) of just over $3 million, demonstrating notable early traction in a growing market.

The company’s core product leverages specialty-specific AI voice agents—tailored to practices such as orthopedics, dermatology, OB-GYN, and dentistry—to handle high-volume, repetitive tasks like appointment scheduling, cancellations, and answering FAQs.

By integrating seamlessly with EHR systems, these voice agents reduce patient hold times, enhance scheduling accuracy, and allow staff to concentrate on complex, sensitive interactions.

Recent growth has been fueled by strong funding and compelling operational performance. In August 2025, Assort Health raised $50 million in Series B funding, at a valuation of $750 million, just four months after its Series A, signaling investor confidence in its rapid adoption and business model.

Earlier in April 2025, the company raised $26 million in institutional financing, citing 8× revenue growth since Q4 2024, broad adoption across specialties, and operational results like cutting hold times from ~11 minutes to under a minute in pilot clinics.